Antiviral drugs for cytomegalovirus diseases
Top Cited Papers
- 1 September 2006
- journal article
- review article
- Published by Elsevier in Antiviral Research
- Vol. 71 (2-3) , 154-163
- https://doi.org/10.1016/j.antiviral.2006.05.002
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- Cytomegalovirus infection in solid organ transplant recipients: New challenges and their implications for preventive strategiesJournal of Clinical Virology, 2006
- Acyclic nucleoside phosphonates: a key class of antiviral drugsNature Reviews Drug Discovery, 2005
- ValganciclovirDrugs, 2005
- Mechanism of Action of the Ribopyranoside Benzimidazole GW275175X against Human CytomegalovirusAntimicrobial Agents and Chemotherapy, 2004
- Valacyclovir Provides Optimum Acyclovir Exposure for Prevention of Cytomegalovirus and Related Outcomes after Organ TransplantationThe Journal of Infectious Diseases, 2002
- Potent and Selective Inhibition of Human Cytomegalovirus Replication by 1263W94, a Benzimidazole l -Riboside with a Unique Mode of ActionAntimicrobial Agents and Chemotherapy, 2002
- Susceptibilities of Human Cytomegalovirus Clinical Isolates to BAY38-4766, BAY43-9695, and GanciclovirAntimicrobial Agents and Chemotherapy, 2001
- Valacyclovir for the Prevention of Cytomegalovirus Disease after Renal TransplantationNew England Journal of Medicine, 1999
- Treatment of Cytomegalovirus Retinitis with a Sustained-Release Ganciclovir ImplantNew England Journal of Medicine, 1997
- Design, Synthesis, and Antiviral Activity of Certain 2,5,6-Trihalo-1-(.beta.-D-ribofuranosyl)benzimidazolesJournal of Medicinal Chemistry, 1995